Statin, Ezetimibe, or Fibrate Initiation and Subsequent Use for the Primary and Secondary Prevention of Cardiovascular Diseases among Japanese Patients Aged ≥55 Years: A Nationwide Cohort Study
Author:
Affiliation:
1. Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University
2. Faculty of Health and Welfare, Tokushima Bunri University
Publisher
Pharmaceutical Society of Japan
Subject
Pharmaceutical Science,Pharmacology,General Medicine
Link
https://www.jstage.jst.go.jp/article/bpb/46/11/46_b23-00336/_pdf
Reference38 articles.
1. 1) Michos ED, McEvoy JW, Blumenthal RS. Lipid management for the prevention of atherosclerotic cardiovascular disease. N. Engl. J. Med., 381, 1557–1567 (2019).
2. 2) Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA, 298, 299–308 (2007).
3. 3) WHO. “Cardiovascular diseases.”: ‹http://www.who.int/mediacentre/factsheets/fs317/en/›, accessed 12 April, 2023.
4. 4) The Ministry of Health, Labour and Welfare. “Summary of the 2021 vital statistics monthly report, summary.”: ‹https://www.mhlw.go.jp/toukei/saikin/hw/jinkou/geppo/nengai21/index.html›, accessed 12 April, 2023.
5. 5) Gencer B, Marston NA, Im K, Cannon CP, Sever P, Keech A, Braunwald E, Giugliano RP, Sabatine MS. Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials. Lancet, 396, 1637–1643 (2020).
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Quantification of Oversupply of Chronic Disease Medications among Patients Aged ≥55 Years in Japan;Biological and Pharmaceutical Bulletin;2024-06-12
2. Management of a patient at very high cardiovascular risk with myositis during high-intensity statin therapy;Meditsinskiy sovet = Medical Council;2024-05-19
3. Protective Effect of Pemafibrate Treatment against Diabetic Retinopathy in Spontaneously Diabetic Torii Fatty Rats;Biological and Pharmaceutical Bulletin;2024-03-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3